Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

16 Nov 2012 07:00

RNS Number : 2676R
Gleeson(M J)Group PLC
16 November 2012
 



Friday 16 November 2012

 

 

M J GLEESON GROUP PLC

 

INTERIM MANAGEMENT STATEMENT

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 July 2012 to 15 November 2012, in accordance with the UK Listing Authority's Disclosure and Transparency Rules.

 

Gleeson operates as the following divisions:

 

·; a housebuilder, mainly in the North of England, with a particular focus on low cost homes for local people;

 

·; a strategic land development business, mainly in the South of England, that enhances the value of land, principally held under option, through the planning process;

 

Gleeson Homes

 

Total sales, comprising reserved, contracted and completed homes, are up by 42% from a year ago.

 

Since the beginning of the period we have opened six new sites, two in each region. A total of 26 sites are currently open.

 

Prices for units being sold are in line with management's expectations at an average of £119,000. This is a decrease of £9,000 from the prior year due to a change in geographic mix. The proportion of units being sold on recently acquired higher margin sites has improved significantly since the prior year, with only 25% of total sales noted above from old, low margin sites, compared to 64% in the comparable period.

 

The housing market in the North of England remains challenging and weekly sales rates have on occasion fallen below expectations. Nonetheless, the division's very successful control of costs, coupled with the substantial increase in the number of new higher margin selling outlets, has meant that the overall level of sales achieved during the period will deliver a substantially improved level of profitability.

 

As previously reported, mortgage availability continues to remain restricted. However, we have seen a significant level of interest in the Government's FirstBuy scheme, which provides support to first time buyers by way of a 20% equity loan. In addition, Gleeson Homes is one of the first developers to have secured a low interest loan for site specific development from the Government's Get Britain Building Fund.

 

Five sites have been purchased during the period, which have added 331 plots to the Group's land bank. The Group is currently in discussions regarding the acquisition of a further 13 sites, which, if purchased, will add 1,082 plots to the land bank, taking the total number of plots to in excess of 3,700.

 

Gleeson Strategic Land

 

During the period, Gleeson Strategic Land has sold two significant sites and continues to replenish the portfolio, entering three new agreements since 1 July 2012, comprising 170 acres and, potentially, 1,000 plots.

 

The volume housebuilders continue to display a strong appetite for green field residential land in the South of England and Gleeson Strategic Land is experiencing a high level of interest in the sites which it hopes to bring to the market in the remainder of the year.

 

Outlook

 

The Board is encouraged by the achievements of both Gleeson Homes and Gleeson Strategic Land in challenging circumstances and remains confident that they are laying the foundations of a strong and sustainable improvement in the Group's performance.

 

 

 

 

 

 

Enquiries:

 

M J Gleeson Group plc 01252 360 300

 

Jolyon Harrison Chief Executive Officer

Alan Martin Chief Financial Officer

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMMMVKDGZZM
Date   Source Headline
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.